menu
    • menu

    Company profile for NurExone Biologic

    NEW Drugs in Dev: 2
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NurExone Biologic Inc. is a TSX Venture Exchange listed pharmaceutical company that is developing a platform for biologically-guided ExoTherapy to be delivered, non-invasively, to patients who suffered traumatic spinal cord injuries. ExoTherapy was conceptually demonstrated in animal studies at the Technion, Israel Institute of Technology. NurExone is translating the treatment to humans, and the company holds an exclusive worl...
    NurExone Biologic Inc. is a TSX Venture Exchange listed pharmaceutical company that is developing a platform for biologically-guided ExoTherapy to be delivered, non-invasively, to patients who suffered traumatic spinal cord injuries. ExoTherapy was conceptually demonstrated in animal studies at the Technion, Israel Institute of Technology. NurExone is translating the treatment to humans, and the company holds an exclusive worldwide license from the Technion and Tel Aviv University for the development and commercialization of the technology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NurExone BiologicIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    9 Mezada St., BSR 3 Tower, 30 Fl., Bnei-Brak, 5120109
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nurexone.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nurexone-biologic/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NBiologic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NurExone Announces Corporate Updates
    NurExone Announces Corporate Updates

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253750/0/en/NurExone-Announces-Corporate-Updates.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    NurExone to Show Regenerative Medicine Platform at NANO.IL.2026
    NurExone to Show Regenerative Medicine Platform at NANO.IL.2026

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246788/0/en/NurExone-to-Showcase-Its-Regenerative-Medicine-Platform-at-NANO-IL-2026-and-Advanced-Therapies-Congress-in-March-2026-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Nurexone Appoints Eyal Gabbai to Healthcare Board
    Nurexone Appoints Eyal Gabbai to Healthcare Board

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229770/0/en/NurExone-Appoints-Eyal-Gabbai-to-Board-Adding-Large-Scale-Healthcare-System-and-Capital-Markets-Expertise.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Nurexone Demonstrates Exosome Anti-Inflammatory Activity In Lab
    Nurexone Demonstrates Exosome Anti-Inflammatory Activity In Lab

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208729/0/en/NurExone-Reports-Anti-Inflammatory-Activity-of-Its-Exosomes-in-Lab-Analysis.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    NurExone Initiates Small-Scale ExoPTEN Clinical Manufacturing
    NurExone Initiates Small-Scale ExoPTEN Clinical Manufacturing

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204856/0/en/NurExone-Plans-Small-Scale-of-ExoPTEN-Clinical-Manufacturing-in-Preparation-for-FUTURE-First-in-Human-USE-Pathways.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Nurexone Biologic Reveals Q3 2025 Financials & Corporate Update
    Nurexone Biologic Reveals Q3 2025 Financials & Corporate Update

    28 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/28/3196317/0/en/NurExone-Biologic-Inc-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    28 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search